世界の短腸症候群(SBS)市場規模・現状・予測2021-2027

【英語タイトル】Global Short Bowel Syndrome (SBS) Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR5225)・商品コード:QY21APR5225
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:96
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、短腸症候群(SBS)の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(経口、非経口)、用途別市場規模(病院、診療所、小売薬局)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・短腸症候群(SBS)の市場動向
・企業の競争状況、市場シェア
・短腸症候群(SBS)の種類別市場規模(経口、非経口)
・短腸症候群(SBS)の用途別市場規模(病院、診療所、小売薬局)
・短腸症候群(SBS)の北米市場規模2016-2027(アメリカ、カナダ)
・短腸症候群(SBS)の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・短腸症候群(SBS)のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・短腸症候群(SBS)の中南米市場規模2016-2027(メキシコ、ブラジル)
・短腸症候群(SBS)の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Merck、Takeda、Emmaus Medical、Ardelyx、Naia Pharmaceuticals、Nutrinia、OxThera、Sancilio Pharmaceuticals、Zealand Pharma)
・結論
【レポートの概要】

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
During 2017, the parental route segment accounted for the major shares and dominated the SBS market. Factors such as the rapid action mechanism of the drug and the prolonged action result contribute to the growth of this market segment in the coming years. In the parental route, the drug is administered intravenously, subcutaneously, intrathecally, or through intramuscular routes and is applied when the oral route of drug administration is ineffective.

Market Analysis and Insights: Global Short Bowel Syndrome (SBS) Market
The global Short Bowel Syndrome (SBS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Short Bowel Syndrome (SBS) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Short Bowel Syndrome (SBS) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Short Bowel Syndrome (SBS) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Short Bowel Syndrome (SBS) market.

Global Short Bowel Syndrome (SBS) Scope and Market Size
Short Bowel Syndrome (SBS) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Short Bowel Syndrome (SBS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Route
Parental Route

Segment by Application
Hospitals
Clinics
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Short Bowel Syndrome (SBS) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Route
1.2.3 Parental Route
1.3 Market by Application
1.3.1 Global Short Bowel Syndrome (SBS) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Short Bowel Syndrome (SBS) Market Perspective (2016-2027)
2.2 Short Bowel Syndrome (SBS) Growth Trends by Regions
2.2.1 Short Bowel Syndrome (SBS) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Short Bowel Syndrome (SBS) Historic Market Share by Regions (2016-2021)
2.2.3 Short Bowel Syndrome (SBS) Forecasted Market Size by Regions (2022-2027)
2.3 Short Bowel Syndrome (SBS) Industry Dynamic
2.3.1 Short Bowel Syndrome (SBS) Market Trends
2.3.2 Short Bowel Syndrome (SBS) Market Drivers
2.3.3 Short Bowel Syndrome (SBS) Market Challenges
2.3.4 Short Bowel Syndrome (SBS) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Short Bowel Syndrome (SBS) Players by Revenue
3.1.1 Global Top Short Bowel Syndrome (SBS) Players by Revenue (2016-2021)
3.1.2 Global Short Bowel Syndrome (SBS) Revenue Market Share by Players (2016-2021)
3.2 Global Short Bowel Syndrome (SBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Short Bowel Syndrome (SBS) Revenue
3.4 Global Short Bowel Syndrome (SBS) Market Concentration Ratio
3.4.1 Global Short Bowel Syndrome (SBS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Short Bowel Syndrome (SBS) Revenue in 2020
3.5 Short Bowel Syndrome (SBS) Key Players Head office and Area Served
3.6 Key Players Short Bowel Syndrome (SBS) Product Solution and Service
3.7 Date of Enter into Short Bowel Syndrome (SBS) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Short Bowel Syndrome (SBS) Breakdown Data by Type
4.1 Global Short Bowel Syndrome (SBS) Historic Market Size by Type (2016-2021)
4.2 Global Short Bowel Syndrome (SBS) Forecasted Market Size by Type (2022-2027)

5 Short Bowel Syndrome (SBS) Breakdown Data by Application
5.1 Global Short Bowel Syndrome (SBS) Historic Market Size by Application (2016-2021)
5.2 Global Short Bowel Syndrome (SBS) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Short Bowel Syndrome (SBS) Market Size (2016-2027)
6.2 North America Short Bowel Syndrome (SBS) Market Size by Type
6.2.1 North America Short Bowel Syndrome (SBS) Market Size by Type (2016-2021)
6.2.2 North America Short Bowel Syndrome (SBS) Market Size by Type (2022-2027)
6.2.3 North America Short Bowel Syndrome (SBS) Market Size by Type (2016-2027)
6.3 North America Short Bowel Syndrome (SBS) Market Size by Application
6.3.1 North America Short Bowel Syndrome (SBS) Market Size by Application (2016-2021)
6.3.2 North America Short Bowel Syndrome (SBS) Market Size by Application (2022-2027)
6.3.3 North America Short Bowel Syndrome (SBS) Market Size by Application (2016-2027)
6.4 North America Short Bowel Syndrome (SBS) Market Size by Country
6.4.1 North America Short Bowel Syndrome (SBS) Market Size by Country (2016-2021)
6.4.2 North America Short Bowel Syndrome (SBS) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Short Bowel Syndrome (SBS) Market Size (2016-2027)
7.2 Europe Short Bowel Syndrome (SBS) Market Size by Type
7.2.1 Europe Short Bowel Syndrome (SBS) Market Size by Type (2016-2021)
7.2.2 Europe Short Bowel Syndrome (SBS) Market Size by Type (2022-2027)
7.2.3 Europe Short Bowel Syndrome (SBS) Market Size by Type (2016-2027)
7.3 Europe Short Bowel Syndrome (SBS) Market Size by Application
7.3.1 Europe Short Bowel Syndrome (SBS) Market Size by Application (2016-2021)
7.3.2 Europe Short Bowel Syndrome (SBS) Market Size by Application (2022-2027)
7.3.3 Europe Short Bowel Syndrome (SBS) Market Size by Application (2016-2027)
7.4 Europe Short Bowel Syndrome (SBS) Market Size by Country
7.4.1 Europe Short Bowel Syndrome (SBS) Market Size by Country (2016-2021)
7.4.2 Europe Short Bowel Syndrome (SBS) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Short Bowel Syndrome (SBS) Market Size (2016-2027)
8.2 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Type
8.2.1 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Type (2016-2027)
8.3 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Application
8.3.1 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Application (2016-2027)
8.4 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region
8.4.1 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Short Bowel Syndrome (SBS) Market Size (2016-2027)
9.2 Latin America Short Bowel Syndrome (SBS) Market Size by Type
9.2.1 Latin America Short Bowel Syndrome (SBS) Market Size by Type (2016-2021)
9.2.2 Latin America Short Bowel Syndrome (SBS) Market Size by Type (2022-2027)
9.2.3 Latin America Short Bowel Syndrome (SBS) Market Size by Type (2016-2027)
9.3 Latin America Short Bowel Syndrome (SBS) Market Size by Application
9.3.1 Latin America Short Bowel Syndrome (SBS) Market Size by Application (2016-2021)
9.3.2 Latin America Short Bowel Syndrome (SBS) Market Size by Application (2022-2027)
9.3.3 Latin America Short Bowel Syndrome (SBS) Market Size by Application (2016-2027)
9.4 Latin America Short Bowel Syndrome (SBS) Market Size by Country
9.4.1 Latin America Short Bowel Syndrome (SBS) Market Size by Country (2016-2021)
9.4.2 Latin America Short Bowel Syndrome (SBS) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Short Bowel Syndrome (SBS) Market Size (2016-2027)
10.2 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Type
10.2.1 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Type (2016-2027)
10.3 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Application
10.3.1 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Application (2016-2027)
10.4 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country
10.4.1 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Short Bowel Syndrome (SBS) Introduction
11.1.4 Merck Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Short Bowel Syndrome (SBS) Introduction
11.2.4 Takeda Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.2.5 Takeda Recent Development
11.3 Emmaus Medical
11.3.1 Emmaus Medical Company Details
11.3.2 Emmaus Medical Business Overview
11.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Introduction
11.3.4 Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.3.5 Emmaus Medical Recent Development
11.4 Ardelyx
11.4.1 Ardelyx Company Details
11.4.2 Ardelyx Business Overview
11.4.3 Ardelyx Short Bowel Syndrome (SBS) Introduction
11.4.4 Ardelyx Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.4.5 Ardelyx Recent Development
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Company Details
11.5.2 Naia Pharmaceuticals Business Overview
11.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Introduction
11.5.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.5.5 Naia Pharmaceuticals Recent Development
11.6 Nutrinia
11.6.1 Nutrinia Company Details
11.6.2 Nutrinia Business Overview
11.6.3 Nutrinia Short Bowel Syndrome (SBS) Introduction
11.6.4 Nutrinia Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.6.5 Nutrinia Recent Development
11.7 OxThera
11.7.1 OxThera Company Details
11.7.2 OxThera Business Overview
11.7.3 OxThera Short Bowel Syndrome (SBS) Introduction
11.7.4 OxThera Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.7.5 OxThera Recent Development
11.8 Sancilio Pharmaceuticals
11.8.1 Sancilio Pharmaceuticals Company Details
11.8.2 Sancilio Pharmaceuticals Business Overview
11.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Introduction
11.8.4 Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.8.5 Sancilio Pharmaceuticals Recent Development
11.9 Zealand Pharma
11.9.1 Zealand Pharma Company Details
11.9.2 Zealand Pharma Business Overview
11.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Introduction
11.9.4 Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Business (2016-2021)
11.9.5 Zealand Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Short Bowel Syndrome (SBS) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Route
Table 3. Key Players of Parental Route
Table 4. Global Short Bowel Syndrome (SBS) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Short Bowel Syndrome (SBS) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Short Bowel Syndrome (SBS) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Short Bowel Syndrome (SBS) Market Share by Regions (2016-2021)
Table 8. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Short Bowel Syndrome (SBS) Market Share by Regions (2022-2027)
Table 10. Short Bowel Syndrome (SBS) Market Trends
Table 11. Short Bowel Syndrome (SBS) Market Drivers
Table 12. Short Bowel Syndrome (SBS) Market Challenges
Table 13. Short Bowel Syndrome (SBS) Market Restraints
Table 14. Global Short Bowel Syndrome (SBS) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Short Bowel Syndrome (SBS) Market Share by Players (2016-2021)
Table 16. Global Top Short Bowel Syndrome (SBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome (SBS) as of 2020)
Table 17. Ranking of Global Top Short Bowel Syndrome (SBS) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Short Bowel Syndrome (SBS) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Short Bowel Syndrome (SBS) Product Solution and Service
Table 21. Date of Enter into Short Bowel Syndrome (SBS) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Short Bowel Syndrome (SBS) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2016-2021)
Table 25. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Short Bowel Syndrome (SBS) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Short Bowel Syndrome (SBS) Revenue Market Share by Application (2016-2021)
Table 29. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Short Bowel Syndrome (SBS) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Short Bowel Syndrome (SBS) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Short Bowel Syndrome (SBS) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Short Bowel Syndrome (SBS) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Short Bowel Syndrome (SBS) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Short Bowel Syndrome (SBS) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Short Bowel Syndrome (SBS) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Short Bowel Syndrome (SBS) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Short Bowel Syndrome (SBS) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Short Bowel Syndrome (SBS) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Short Bowel Syndrome (SBS) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Short Bowel Syndrome (SBS) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Short Bowel Syndrome (SBS) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Short Bowel Syndrome (SBS) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Short Bowel Syndrome (SBS) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Short Bowel Syndrome (SBS) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Short Bowel Syndrome (SBS) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Short Bowel Syndrome (SBS) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Short Bowel Syndrome (SBS) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Short Bowel Syndrome (SBS) Product
Table 64. Merck Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Takeda Company Details
Table 67. Takeda Business Overview
Table 68. Takeda Short Bowel Syndrome (SBS) Product
Table 69. Takeda Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 70. Takeda Recent Development
Table 71. Emmaus Medical Company Details
Table 72. Emmaus Medical Business Overview
Table 73. Emmaus Medical Short Bowel Syndrome (SBS) Product
Table 74. Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 75. Emmaus Medical Recent Development
Table 76. Ardelyx Company Details
Table 77. Ardelyx Business Overview
Table 78. Ardelyx Short Bowel Syndrome (SBS) Product
Table 79. Ardelyx Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 80. Ardelyx Recent Development
Table 81. Naia Pharmaceuticals Company Details
Table 82. Naia Pharmaceuticals Business Overview
Table 83. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Product
Table 84. Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 85. Naia Pharmaceuticals Recent Development
Table 86. Nutrinia Company Details
Table 87. Nutrinia Business Overview
Table 88. Nutrinia Short Bowel Syndrome (SBS) Product
Table 89. Nutrinia Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 90. Nutrinia Recent Development
Table 91. OxThera Company Details
Table 92. OxThera Business Overview
Table 93. OxThera Short Bowel Syndrome (SBS) Product
Table 94. OxThera Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 95. OxThera Recent Development
Table 96. Sancilio Pharmaceuticals Company Details
Table 97. Sancilio Pharmaceuticals Business Overview
Table 98. Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 99. Sancilio Pharmaceuticals Recent Development
Table 100. Zealand Pharma Company Details
Table 101. Zealand Pharma Business Overview
Table 102. Zealand Pharma Short Bowel Syndrome (SBS) Product
Table 103. Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Business (2016-2021) & (US$ Million)
Table 104. Zealand Pharma Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Short Bowel Syndrome (SBS) Market Share by Type: 2020 VS 2027
Figure 2. Oral Route Features
Figure 3. Parental Route Features
Figure 4. Global Short Bowel Syndrome (SBS) Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Short Bowel Syndrome (SBS) Report Years Considered
Figure 9. Global Short Bowel Syndrome (SBS) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Short Bowel Syndrome (SBS) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Short Bowel Syndrome (SBS) Market Share by Regions: 2020 VS 2027
Figure 12. Global Short Bowel Syndrome (SBS) Market Share by Regions (2022-2027)
Figure 13. Global Short Bowel Syndrome (SBS) Market Share by Players in 2020
Figure 14. Global Top Short Bowel Syndrome (SBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome (SBS) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Short Bowel Syndrome (SBS) Revenue in 2020
Figure 16. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2016-2021)
Figure 17. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2022-2027)
Figure 18. North America Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Short Bowel Syndrome (SBS) Market Share by Type (2016-2027)
Figure 20. North America Short Bowel Syndrome (SBS) Market Share by Application (2016-2027)
Figure 21. North America Short Bowel Syndrome (SBS) Market Share by Country (2016-2027)
Figure 22. United States Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Short Bowel Syndrome (SBS) Market Share by Type (2016-2027)
Figure 26. Europe Short Bowel Syndrome (SBS) Market Share by Application (2016-2027)
Figure 27. Europe Short Bowel Syndrome (SBS) Market Share by Country (2016-2027)
Figure 28. Germany Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Short Bowel Syndrome (SBS) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Short Bowel Syndrome (SBS) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Short Bowel Syndrome (SBS) Market Share by Region (2016-2027)
Figure 38. China Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Short Bowel Syndrome (SBS) Market Share by Type (2016-2027)
Figure 46. Latin America Short Bowel Syndrome (SBS) Market Share by Application (2016-2027)
Figure 47. Latin America Short Bowel Syndrome (SBS) Market Share by Country (2016-2027)
Figure 48. Mexico Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Short Bowel Syndrome (SBS) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Short Bowel Syndrome (SBS) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Short Bowel Syndrome (SBS) Market Share by Country (2016-2027)
Figure 54. Turkey Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Short Bowel Syndrome (SBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 58. Takeda Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 59. Emmaus Medical Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 60. Ardelyx Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 61. Naia Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 62. Nutrinia Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 63. OxThera Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 64. Sancilio Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 65. Zealand Pharma Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


【掲載企業】

Merck、Takeda、Emmaus Medical、Ardelyx、Naia Pharmaceuticals、Nutrinia、OxThera、Sancilio Pharmaceuticals、Zealand Pharma

★調査レポート[世界の短腸症候群(SBS)市場規模・現状・予測2021-2027] (コード:QY21APR5225)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の短腸症候群(SBS)市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆